Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge
Top Cited Papers
- 7 September 2014
- journal article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 20 (10), 1126-1129
- https://doi.org/10.1038/nm.3702
Abstract
Ebolavirus disease causes high mortality, and the current outbreak has spread unabated through West Africa. Human adenovirus type 5 vectors (rAd5) encoding ebolavirus glycoprotein (GP) generate protective immunity against acute lethal Zaire ebolavirus (EBOV) challenge in macaques, but fail to protect animals immune to Ad5, suggesting natural Ad5 exposure may limit vaccine efficacy in humans. Here we show that a chimpanzee-derived replication-defective adenovirus (ChAd) vaccine also rapidly induced uniform protection against acute lethal EBOV challenge in macaques. Because protection waned over several months, we boosted ChAd3 with modified vaccinia Ankara (MVA) and generated, for the first time, durable protection against lethal EBOV challenge.Keywords
This publication has 27 references indexed in Scilit:
- Transcriptional Profiling of the Circulating Immune Response to Lassa Virus in an Aerosol Model of ExposurePLoS Neglected Tropical Diseases, 2013
- Clinical Assessment of a Recombinant Simian Adenovirus ChAd63: A Potent New Vaccine VectorThe Journal of Infectious Diseases, 2012
- Novel Adenovirus-Based Vaccines Induce Broad and Sustained T Cell Responses to HCV in ManScience Translational Medicine, 2012
- Vaccine Vectors Derived from a Large Collection of Simian Adenoviruses Induce Potent Cellular Immunity Across Multiple SpeciesScience Translational Medicine, 2012
- Recombinant Adenovirus Serotype 26 (Ad26) and Ad35 Vaccine Vectors Bypass Immunity to Ad5 and Protect Nonhuman Primates against Ebolavirus ChallengeJournal of Virology, 2011
- SPICE: Exploration and analysis of post‐cytometric complex multivariate datasetsCytometry Part A, 2011
- Vector Choice Determines Immunogenicity and Potency of Genetic Vaccines against Angola Marburg Virus in Nonhuman PrimatesJournal of Virology, 2010
- Prime-Boost Immunization with Adenoviral and Modified Vaccinia Virus Ankara Vectors Enhances the Durability and Polyfunctionality of Protective Malaria CD8 + T-Cell ResponsesInfection and Immunity, 2010
- Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania majorNature Medicine, 2007
- Immune Protection of Nonhuman Primates against Ebola Virus with Single Low-Dose Adenovirus Vectors Encoding Modified GPsPLoS Medicine, 2006